Funds and ETFs Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 09:05:21 10/05/2024 pm IST 5-day change 1st Jan Change
155.5 EUR -0.13% Intraday chart for Merck KGaA +2.30% +7.91%

ETFs positioned on Merck KGaA

Name Weight AuM 1st Jan change Investor Rating
0.05% 7 M€ +0.11% -
0.05% 23 M€ -.--% -
0.05% 786 M€ -.--%
0.05% 284 M€ -.--%
0.05% 0 M€ +18.92%
0.05% 206 M€ -.--%
0.04% 1,166 M€ +0.26%
0.04% 607 M€ +0.05%
0.04% 0 M€ +8.70% -
0.04% 0 M€ 0.00% -
0.03% 0 M€ +8.24% -
0.02% 0 M€ +5.79% -
0.02% 0 M€ +5.63% -
0.02% 0 M€ +3.50% -
0.02% 0 M€ +2.80% -
0.01% 0 M€ +3.63% -
0.01% 0 M€ +2.72% -
0.01% 0 M€ +0.32% -
0.01% 0 M€ +0.50% -
0.00% 0 M€ -2.58% -
0.00% 0 M€ 0.00% -
0.00% 0 M€ -2.25% -
0.00% 0 M€ -3.22% -
298.38% 0 M€ +10.39% -
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
155.5 EUR
Average target price
179.8 EUR
Spread / Average Target
+15.64%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Funds and ETFs Merck KGaA
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW